Clinical Research Directory
Browse clinical research sites, groups, and studies.
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Sponsor: Alzheimer's Light LLC
Summary
Electrical activity in the brain known as "gamma" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per second or 40Hz increased gamma brainwaves and led to clearing of beta amyloid plaques in the brain, a key abnormality in Alzheimer's disease. This project will test the ability of a novel iPad App (AlzLife https://www.alz.life/) that delivers light therapy at 40 Hz combined with cognitive therapy to improve cognition, function, and quality of life in Alzheimer's disease.
Official title: An Observational Trial of Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
OBSERVATIONAL
Enrollment
2000
Start Date
2018-01-01
Completion Date
2029-12-31
Last Updated
2024-08-01
Healthy Volunteers
Yes
Conditions
Interventions
Combination of 40Hz light and cognitive therapy (ALZLIFE)
Combination of 40Hz light and cognitive therapy delivered by iPad application ALZLIFE
Locations (1)
Andrey Vyshedskiy
Miami, Florida, United States